SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cerevel Therapeutics
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 31 2025
0mins
Source: PRnewswire
Class Action Filed: A class action lawsuit has been initiated against Cerevel Therapeutics, Bain Capital, and Pfizer for alleged violations of federal securities laws, affecting investors who sold or held shares during specified periods related to a merger with AbbVie.
Investor Outreach: Faruqi & Faruqi, LLP is encouraging affected investors to contact them directly to discuss their legal options and the upcoming deadline to seek lead plaintiff status in the case.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
